Latest From Medscape UK
For You: Latest News & Resources
Clinical Summary
A retrospective cohort of around 183,000 UK women followed up to 21 years.
Clinical Summary
And in those with established T2D, denosumab, rather than bisphosphonates, is associated with other beneficial outcomes.
Clinical Summary